These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18182657)

  • 1. Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
    Thomas MB; Davila M; Abbruzzese JL
    J Clin Oncol; 2008 Jan; 26(2):172-4. PubMed ID: 18182657
    [No Abstract]   [Full Text] [Related]  

  • 2. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
    Liu CJ; Kao JH
    J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the relationship between genotype D of hepatitis B virus and hepatocellular carcinoma].
    Xu ZJ; Zhang JL; Yang H; Zhang QH; Chen XL
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):385-6. PubMed ID: 15918981
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
    Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
    Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.
    Tseng TC; Kao JH
    Gastroenterology; 2008 Apr; 134(4):1272-3; author reply 1273. PubMed ID: 18395116
    [No Abstract]   [Full Text] [Related]  

  • 7. Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
    Elkady A; Tanaka Y; Kurbanov F; Oynsuren T; Mizokami M
    J Gastroenterol Hepatol; 2008 Mar; 23(3):474-81. PubMed ID: 18318825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma.
    Bonilla Guerrero R; Roberts LR
    J Hepatol; 2005 May; 42(5):760-77. PubMed ID: 15826727
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.
    Hoshida Y
    J Hepatol; 2009 Nov; 51(5):842-4. PubMed ID: 19748698
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Integration of hepatitis B virus DNA in liver tissues from patients with hepatocellular carcinoma and liver cirrhosis].
    Zhang PY; Wang YY; Cheng J; Lang ZW; Yang Q; Zhang JZ; Huang DZ; Yang YJ
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):389-90. PubMed ID: 15918983
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.
    Chung RT
    Cancer; 2005 Feb; 103(4):654-6. PubMed ID: 15641028
    [No Abstract]   [Full Text] [Related]  

  • 16. Preventing infection-associated cancer: from bench to hillside.
    Goedert JJ
    J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations of T-cell epitopes in the hepatitis B virus surface gene in children with chronic infection and hepatocellular carcinoma.
    Ni YH; Chang MH; Hsu HY; Tung YC; Chen HL; Wang KJ; Tsuei DJ; Young NC
    Am J Gastroenterol; 2008 Apr; 103(4):1004-9. PubMed ID: 18190649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.
    Dong Q; Chan HL; Liu Z; Chan DP; Zhang B; Chen Y; Kung HF; Sung JJ; He ML
    Biochem Biophys Res Commun; 2008 Oct; 374(4):773-6. PubMed ID: 18675784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus induced hepatocellular carcinoma.
    Chemin I; Zoulim F
    Cancer Lett; 2009 Dec; 286(1):52-9. PubMed ID: 19147276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.
    Sung FY; Jung CM; Wu CF; Lin CL; Liu CJ; Liaw YF; Tsai KS; Yu MW
    Gastroenterology; 2009 Nov; 137(5):1687-97. PubMed ID: 19664630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.